| J3245 | Injection, tildrakizumab, 1 mg | 4,400 | $110 | $484K |
| J2357 | Injection, omalizumab, 5 mg | 5,420 | $30 | $146.2K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 15,020 | $10 | $120.1K |
| J0897 | Injection, denosumab, 1 mg | 6,660 | $20 | $119.9K |
| J1306 | Injection, inclisiran, 1 mg | 4,260 | $10 | $38.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 220 | $50 | $9.9K |
| 96366 | The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease. | 300 | $20 | $4.5K |
| 96372 | A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician… | 440 | $10 | $4.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 50 | $80 | $4.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 50 | $80 | $3.9K |